Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cabergoline vs Calcium Infusion for OHSS Prevention
NCT03473613Phase 3Completed
- Sponsor
- Benha University
- Start
- Oct 2014
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cabergoline in ovarian hyperstimulation syndrome (OHSS), sponsored by Benha University. Started Oct 2014; status: completed.
02
Drugs
cabergoline
03
Conditions
ovarian hyperstimulation syndrome (OHSS)
Beyond the preview
Go deeper on NCT03473613.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03473613.